Matthew L Peterson

The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.

Örn Almarsson, Matthew L Peterson, Michael Zaworotko, 2012, Pharmaceutical patent analyst.

Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

Orn Almarsson, Matthew L Peterson, M. Peterson, 2003, Journal of the American Chemical Society.

High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.

Michael J Cima, Orn Almarsson, Matthew L Peterson, 2004, Advanced drug delivery reviews.

Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.

Matthew L Peterson, Magali B Hickey, Peter W Stephens, 2007, Molecular pharmaceutics.

Improved pharmacokinetics of AMG 517 through co-crystallization part 2: analysis of 12 carboxylic acid co-crystals.

Matthew L Peterson, M. Peterson, E. Munson, 2011, Journal of pharmaceutical sciences.

Improved pharmacokinetics of AMG 517 through co-crystallization. Part 1: comparison of two acids with corresponding amide co-crystals.

Matthew L Peterson, M. Peterson, E. Munson, 2010, Journal of pharmaceutical sciences.

The predictably elusive form II of aspirin.

Peddy Vishweshwar, Matthew L Peterson, Michael J Zaworotko, 2005, Journal of the American Chemical Society.

Performance comparison of a co-crystal of carbamazepine with marketed product.

Orn Almarsson, Matthew L Peterson, Michael J Zaworotko, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.